What they were paid
Arcutis Biotherapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $60,000 | $102,722 | $189,734 | $0 | $352,456 |
| FY2024 | $60,000 | $87,500 | $162,500 | $0 | $310,000 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Arcutis Biotherapeutics, Inc. DEF 14A filed April 21, 2026, accession 0001787306-26-000028, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Arcutis Biotherapeutics pays directors a $50,000 cash retainer and $300,000 in Options and RSUs.
Committees
FY2025 · as the proxy prints themNominating/Governance
The rest of the Arcutis Biotherapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Amit D. Munshi | Independent Director | $499,243 |
| Bhaskar Chaudhuri | Independent Director | $352,510 |
| Halley Gilbert | Independent Director | $352,456 |
| Howard G. Welgus | Independent Director | $347,456 |
| Keith R. Leonard | Independent Director | $384,956 |
| Neha Krishnamohan | Independent Director | $352,456 |
| Patrick J. Heron | Independent Director | $349,956 |
| Sue-Jean Lin | Independent Director | $367,456 |
| Todd Franklin Watanabe | Director | $0 |
The full Arcutis Biotherapeutics compensation record
free company briefThis page is one director within Arcutis Biotherapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat